Co-Diagnostics, Inc.
SEC CIK 1692415 · CODX · last insider filing 2026-05-27
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Serbin Richard S | Director | filed 2017 - 2026 |
| Nelson James B | Director | filed 2019 - 2026 |
| Egan Dwight H | Director · Chief Executive Officer | filed 2017 - 2026 |
| Murphy Edward L. | Director | filed 2019 - 2026 |
| Durenard Eugene | Director | filed 2020 - 2026 |
| Murphy TED | Director | filed 2022 - 2025 |
| Satterfield Brent | Director · Former Chief Science Officer | filed 2017 - 2021 |
| Borkowski Edward | Director | filed 2017 - 2017 |
| Kiesner Frank J | Director | filed 2017 - 2017 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Brown Brian Lee | Chief Financial Officer | filed 2021 - 2026 |
| Abbott Richard David | President | filed 2024 - 2026 |
| Benson Reed L | General Counsel | filed 2017 - 2021 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.